BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38199691)

  • 1. Triclabendazole efficacy, prevalence, and re-infection of Fasciola hepatica in bovine and ovine naturally infected in the Andes of Ecuador.
    Rodríguez-Hidalgo R; Calvopiña M; Romero-Alvarez D; Montenegro-Franco M; Pavon D; Pointier JP; Benítez-Ortiz W; Celi-Erazo M
    Vet Parasitol Reg Stud Reports; 2024 Jan; 47():100947. PubMed ID: 38199691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clonal amplification of Fasciola hepatica in Galba truncatula: within and between isolate variation of triclabendazole-susceptible and -resistant clones.
    Hodgkinson JE; Cwiklinski K; Beesley N; Hartley C; Allen K; Williams DJL
    Parasit Vectors; 2018 Jun; 11(1):363. PubMed ID: 29941045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance of Fasciola hepatica against Triclabendazole in cattle in Cajamarca (Peru): a clinical trial and an in vivo efficacy test in sheep.
    Ortiz P; Scarcella S; Cerna C; Rosales C; Cabrera M; Guzmán M; Lamenza P; Solana H
    Vet Parasitol; 2013 Jul; 195(1-2):118-21. PubMed ID: 23352107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triclabendazole resistance in Fasciola hepatica: First report in sheep from the Santa Cruz province, Argentinian Patagonia.
    Larroza M; Aguilar M; Soler P; Mora J; Roa M; Cabrera R; Martinez Stanziola JP; Ceballos L; Alvarez LI
    Vet Parasitol Reg Stud Reports; 2023 Oct; 45():100927. PubMed ID: 37783530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standardisation of a coproantigen reduction test (CRT) protocol for the diagnosis of resistance to triclabendazole in Fasciola hepatica.
    Flanagan AM; Edgar HW; Forster F; Gordon A; Hanna RE; McCoy M; Brennan GP; Fairweather I
    Vet Parasitol; 2011 Feb; 176(1):34-42. PubMed ID: 21093156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unchanged triclabendazole kinetics after co-administration with ivermectin and methimazole: failure of its therapeutic activity against triclabendazole-resistant liver flukes.
    Ceballos L; Moreno L; Alvarez L; Shaw L; Fairweather I; Lanusse C
    BMC Vet Res; 2010 Feb; 6():8. PubMed ID: 20128898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fasciola hepatica: a comparative survey of adult fluke resistance to triclabendazole, nitroxynil and closantel on selected upland and lowland sheep farms in Northern Ireland using faecal egg counting, coproantigen ELISA testing and fluke histology.
    Hanna RE; McMahon C; Ellison S; Edgar HW; Kajugu PE; Gordon A; Irwin D; Barley JP; Malone FE; Brennan GP; Fairweather I
    Vet Parasitol; 2015 Jan; 207(1-2):34-43. PubMed ID: 25529143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of fasciolosis and evaluation of drug efficacy against Fasciola hepatica in dairy cattle in the Maffra and Bairnsdale districts of Gippsland, Victoria, Australia.
    Elliott TP; Kelley JM; Rawlin G; Spithill TW
    Vet Parasitol; 2015 Apr; 209(1-2):117-24. PubMed ID: 25771931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of sequestration of triclabendazole and associated metabolites by extracellular vesicles of Fasciola hepatica.
    Davis CN; Winters A; Milic I; Devitt A; Cookson A; Brophy PM; Morphew RM
    Sci Rep; 2020 Aug; 10(1):13445. PubMed ID: 32778698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance of Fasciola hepatica against triclabendazole in cattle and sheep in The netherlands.
    Moll L; Gaasenbeek CP; Vellema P; Borgsteede FH
    Vet Parasitol; 2000 Jul; 91(1-2):153-8. PubMed ID: 10889368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The field evaluation of albendazole and triclabendazole efficacy against Fasciola hepatica by coproantigen ELISA in naturally infected sheep.
    Novobilský A; Averpil HB; Höglund J
    Vet Parasitol; 2012 Nov; 190(1-2):272-6. PubMed ID: 22818198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of flukicides against Fasciola hepatica and first report of triclabendazole resistance on German sheep farms.
    Kahl A; von Samson-Himmelstjerna G; Helm C; Hodgkinson J; Williams D; Weiher W; Terhalle W; Steuber S; Ganter M; Krücken J
    Int J Parasitol Drugs Drug Resist; 2023 Dec; 23():94-105. PubMed ID: 38006779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot Evaluation of Two
    Collett CF; Morphew RM; Timson D; Phillips HC; Brophy PM
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32751696
    [No Abstract]   [Full Text] [Related]  

  • 14. Resistance of Fasciola hepatica against triclabendazole in cattle in Patagonia (Argentina).
    Olaechea F; Lovera V; Larroza M; Raffo F; Cabrera R
    Vet Parasitol; 2011 Jun; 178(3-4):364-6. PubMed ID: 21277090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the therapeutic efficacy of five anthelmintics against natural Fasciola hepatica infections in dairy cattle from the Mantaro Valley, Peru.
    Zárate-Rendón DA; Briones-Montero A; Huaraca-Oré NA; Veirano GS; Levecke B; Geldhof P
    Vet Parasitol Reg Stud Reports; 2023 Feb; 38():100827. PubMed ID: 36725157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of nitroxynil against Fasciola hepatica resistant to triclabendazole in a naturally infected sheep flock.
    Martínez-Valladares M; del Rosario Famularo M; Fernández-Pato N; Castañón-Ordóñez L; Cordero-Pérez C; Rojo-Vázquez FA
    Parasitol Res; 2010 Oct; 107(5):1205-11. PubMed ID: 20680341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of efficacy of triclabendazole against Fasciola hepatica is present on sheep farms in three regions of England, and Wales.
    Kamaludeen J; Graham-Brown J; Stephens N; Miller J; Howell A; Beesley NJ; Hodgkinson J; Learmount J; Williams D
    Vet Rec; 2019 Apr; 184(16):502. PubMed ID: 30824600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of the efficacy of compound alpha and triclabendazole against two isolates of Fasciola hepatica.
    McConville M; Brennan GP; Flanagan A; Edgar HW; Hanna RE; McCoy M; Gordon AW; Castillo R; Hernández-Campos A; Fairweather I
    Vet Parasitol; 2009 May; 162(1-2):75-88. PubMed ID: 19282108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time-course and accumulation of triclabendazole and its metabolites in bile, liver tissues and flukes collected from treated sheep.
    Moreno L; Ceballos L; Fairweather I; Lanusse C; Alvarez L
    Exp Parasitol; 2014 Jan; 136():14-9. PubMed ID: 24211244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of flukicide efficacy against Fasciola hepatica in sheep in Sweden in the absence of a standardised test.
    Novobilský A; Amaya Solis N; Skarin M; Höglund J
    Int J Parasitol Drugs Drug Resist; 2016 Dec; 6(3):141-147. PubMed ID: 27380550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.